The easterly chocolate-brown viper be given to enjoy lurking in hiding spot to capture Australian gnawer . They are thesecond deadliestland snake and can kill a man in under half an hour – but this venom ( and that of the Australia saw - scaled viper ) could have some living - preserve properties . Who would have thought that snake malice may be capable to be used to keep open living ? Well , some savvy scientist , that ’s who .

The team at the University of Queensland has developed a “ venom gel ” comprised of two recombinant ophidian venom proteins . This rapid lesion sealer can lead up blood clotting and prevent lineage clot breakdown . The team come from the Australian Institute for Bioengineering and Nanotechnology ( AIBN ) and has published the newspaper inAdvanced Healthcare Materials .

Venom is normally a very complex matrix , and there are proteins in it that are essential in stock clotting . The venom gel remains in a liquid state but solidifies at a consistence temperature , which will give the exciting attribute of seal wounds . Currently , first assist breeding relies on a veiling product that does not always lay off the bleeding .

Once the spitefulness gel has been train and tested , it could be a spirit - saving add-on to first - aid kits for the public and military .

“ As many as 40 per cent of injury - relate Death are the result of uncontrolled bleeding , and this figure is much higher when it comes to military personnel department with serious bleeding in a scrap zone , ” Amanda Kijas , Postdoctoral Research Fellow work on the projectsaid in a statement . “ Nature has created the most elegant and sophisticated mechanism , and we can repurpose them to deliver people from dying due to uncontrolled bleeding . ”

“ The research shows there is five multiplication less blood loss , and clot take shape three times more quickly when the venom gel is applied , compared to the body ’s natural process . ” enunciate Kijas , “ This even admit multitude with haemophilia and those using blood thinners . ”

Currently , this maliciousness gel is undergoing a pre - clinical testing phase and may be scaled up for commercial use . This work is being conducted with Mark Midwinter from the University of Queensland School of Biomedical Sciences .

“ When a traumatic trauma occur , the complexness of the healing process overcharge the body ’s capacity to control the hemorrhage , ” Kijas said . “ We hope this gel will accelerate the wound - healing processes needed for clotting and lose weight roue flow , ultimately further the body ’s capability to heal large wounds . ”